As filed with the Securities and Exchange Commission on August 7, 2017
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Second Sight Medical Products, Inc.
(Exact name of registrant as specified in its charter)
California | 02-0692322 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
12744 San Fernando Road, Suite 400
Sylmar, California 91342
(818) 833-5000
(Address of Principal Executive Offices, including Zip Code)
Second Sight Medical Products Inc. 2011 Equity Incentive Plan, as amended
Second Sight Medical Products Inc. 2015 Employee Stock Purchase Plan, as amended
(Full title of the plans)
Will McGuire
Chief Executive Officer
Second Sight Medical Products, Inc.
12744 San Fernando Road, Suite 400
Sylmar, California 91342
(Name and address of agent for service)
(818) 833-5000
(Telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer | ☐ | Accelerated filer | ☒ | |||
Non-accelerated filer | ☐ | (do not check if a small reporting company) | Smaller reporting company | ☐ |
1
CALCULATION OF REGISTRATION FEE
Title of Securities to be Registered |
Amount to be Registered (1) |
Proposed Maximum Offering Price per Share |
Proposed Maximum Aggregate Offering Price |
Amount of Registration Fee |
|||
Common Stock, no par value per share | 2,000,000 (2) | $ 1.23 | $ | 2,460,000 | $ | 285.11 | |
Common Stock, no par value per share | 500,000 (3) | $ 1.23 | $ | 615,000 | $ | 71.28 | |
Total | 2,500,000 | $ 1.23 | $ | 3,075,000 (4) | $ | 356.39 |
(1) Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement also covers any additional shares of common stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transactions effected without the registrant’s receipt of consideration that results in an increase in the number of registrant’s outstanding shares of common stock.
(2) Represents additional shares issuable upon exercise of options reserved pursuant to future awards under the amended 2011 Equity Plan.
(3) Represents additional shares of common stock reserved for issuance pursuant to future awards under the 2015 Employee Stock Purchase Plan, as amended.
(4) Estimated in accordance with paragraphs (c) and (h) of Rule 457 under the 1933 Act solely for the purpose of calculating the registration fee on the basis of $1.23 per share which represents the average of the high and low price per share of the Company’s common stock on August 3, 2017 as reported on the Nasdaq Capital Market.
2
Explanatory Note
This Registration Statement on Form S-8 is being filed by Second Sight Medical Products, Inc. (the “Registrant”) to register a total of (i) 2,000,000 additional shares of common stock issuable under the Registrant’s 2011 Equity Incentive Plan, as amended, (the “Option Shares”) and (ii) 500,000 shares of common stock (the “Plan Shares”) issuable under the Registrant’s 2015 Employee Stock Purchase Plan, as amended. The Option Shares and the Plan Shares are in addition to the common stock previously registered for issuance on the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on May 15, 2017 (File No. 333-218016) (the “Prior Registration Statement”).
This Registration Statement relates to securities of the same class as that to which the Prior Registration Statement relates, and is submitted in accordance with General Instruction E to Form S-8 regarding registration of additional securities. Pursuant to such instruction, the contents of the Prior Registration Statement are incorporated by reference and made part of this Registration Statement.
ITEM 8. EXHIBITS.
Exhibit No. | Description of Exhibits | Method of Filing | |
5.1 | Opinion and Consent of Aaron A. Grunfeld | Filed electronically herewith | |
10.4 | 2011 Equity Incentive Plan, as amended (1) | ||
10.17 | 2015 Employee Stock Purchase Plan, as amended (1) | ||
23.1* | Consent of Gumbiner Savett Inc. | Filed electronically herewith | |
23.2* | Consent of Aaron A. Grunfeld (included in Exhibit 5.1). | ||
24.1 | Power of Attorney (Included on the signature page to this registration statement) |
(1) | Incorporated by reference to the registrant’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on May 1, 2017 |
3
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Sylmar, State of California, on August 4, 2017.
SECOND SIGHT MEDICAL PRODUCTS, INC. | ||
By: |
/s/ Jonathan Will McGuire | |
Jonathan Will McGuire | ||
President and Chief Executive Officer |
POWER OF ATTORNEY
Each person whose signature appears below hereby constitutes and appoints Jonathan Will McGuire and Thomas Miller, and each of them, as such person’s true and lawful attorney-in-fact and agent, each with full powers of substitution and re-substitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign any or all amendments (including post effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his or her substitute or substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Name |
Title |
Date | ||
/s/ Jonathan Will McGuire |
President, Chief Executive Officer and Director |
August 4, 2017 | ||
Jonathan Will McGuire | (Principal Executive Officer) | |||
/s/ Thomas B. Miller |
Chief Financial Officer |
August 4, 2017 | ||
Thomas B. Miller | (Principal Financial and Accounting Officer) | |||
/s/ Robert J, Greenberg |
Chairman of the Board of Directors | August 4, 2017 | ||
Robert J. Greenberg M.D., Ph.D. | ||||
Director | August __, 2017 | |||
Gregg Williams |
||||
/s/ William J. Link |
Director | August 4, 2017 | ||
William J. Link | ||||
/s/ Aaron Mendelsohn |
Director | August 4, 2017 | ||
Aaron Mendelsohn | ||||
/s/ Matthew Pfeffer |
Director | August 4, 2017 | ||
Matthew Pfeffer |
4